Inicio・Lista de Acciones・Novo Nordisk A-S (Class B)

Novo Nordisk A-S (Class B)

Abierto

320.1 -1.23

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

318.25

Máximo

326.4

Métricas clave
By Trading Economics
Ingresos	22B 49B
Ventas	18B 97B
P/B Media del Sector	11.87 62.58
BPA	6.63
Rentabilidad por dividendo	3.57
Margen de beneficios	50.15
Empleados	67,900
EBITDA	32B 69B

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+9.53% upside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	3.57% 2.19%
Próximas Ganancias	5 ago 2026
Próxima Fecha de Ex Dividendo	13 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	185B 1.4T
Apertura anterior	321.33
Cierre anterior	320.1

Novo Nordisk A-S (Class B) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 23:56 UTC

Fair Isaac Corp shares are higher in after-market trading, supported by positive investor sentiment and a notable rise in the Nikkei 225 Index.

21 jul 2026, 23:56 UTC

Ulta Beauty Inc. shares are lower in after-market trading, reflecting broader market trends despite positive sentiment from the Nikkei 225 Index surge.

21 jul 2026, 23:56 UTC

American Electric Power shares are lower in after-market hours, continuing a three-session decline and remaining below the 20-day moving average.

21 jul 2026, 23:56 UTC

Mondelez International shares declined in after-market trading, continuing a trend of four consecutive lower daily closes despite earlier gains during the session.

21 jul 2026, 23:56 UTC

Northern Trust shares are higher in after-market trading, reflecting broader positive trends in regional equity indices and renewed investor optimism.

21 jul 2026, 23:56 UTC

Dorian LPG Ltd shares are trading higher in after-market hours, reflecting a gradual increase since Tuesday's close amid broader positive trends in regional equity indices.

21 jul 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

U.S. stock markets rebounded, with the Financial Select Sector SPDR Fund roughly flat in after-hours trading, supported by contributions from SCHW, ICE, FISV, AON, and AXP.

21 jul 2026, 23:56 UTC

No specific news was identified for Alnylam Pharmaceuticals during after-market hours. The stock remains near unchanged since Tuesday's close.

21 jul 2026, 23:56 UTC

Phillips 66 shares are higher in after-market trading, with no specific news identified. Broader market momentum reflects positive investor sentiment amid easing geopolitical tensions.

21 jul 2026, 23:56 UTC

Shake Shack Inc. shares are higher in after-market trading, reflecting a modest gain amid positive sentiment from broader market trends, including a rise in the Nikkei 225 Index.

21 jul 2026, 23:56 UTC

Diamondback Energy Inc shares are lower in after-market hours, continuing a decline since Tuesday's close. Trading has reflected overall weaker performance without specific news.

21 jul 2026, 23:56 UTC

Lumen Technologies Inc. shares are higher in after-market hours, reflecting a modest gain amid broader market weakness and positive sentiment in regional equity indices.

21 jul 2026, 23:56 UTC

Baidu Inc. shares declined in after-market trading, retracing from an early session peak and remaining below recent averages. No specific news was identified.

21 jul 2026, 23:56 UTC

Southern Copper Corp shares are lower in after-market trading, retracing from earlier gains while remaining above their 20-day moving average.

21 jul 2026, 23:56 UTC

Entegris Inc shares are higher in after-market trading, reflecting a notable gain since Tuesday's close amid positive sentiment in regional equity indices.

21 jul 2026, 23:56 UTC

ETF Constituents

Health Care Select Sector SPDR Fund declines after market close, driven by negative returns from Merck, Amgen, and Eli Lilly. The ETF remains near its one-month trading range.

21 jul 2026, 23:52 UTC

Kratos Defense shares are higher in after-market trading, rebounding from earlier losses despite no specific news to explain the movement.

21 jul 2026, 23:51 UTC

Japan's Trade Deficit Expected at -120 Billion Yen Amid Ongoing Economic Challenges and Investor Caution.

21 jul 2026, 23:51 UTC

Japan's June export growth forecasted at 0.186%, crucial for GDP amid stable market expectations and global supply chain challenges.

21 jul 2026, 23:51 UTC

Brazil's Central Bank Signals Potential Interest Rate Cuts Amid Lower Inflation Expectations Ahead of Key COPOM Meeting on July 27, 2026.

21 jul 2026, 23:51 UTC

iShares Core U.S. Aggregate Bond ETF is trading higher in after-market hours amid a general upward trend in global equity indices and positive sentiment in fixed income.

21 jul 2026, 23:51 UTC

News

Regeneron Pharmaceuticals faces a class action lawsuit for securities fraud over misleading claims about Fianlimab-Libtayo trial results. Shares are lower in after-hours trading.

21 jul 2026, 23:51 UTC

Yum China Holdings Inc. shares rose in after-market trading, buoyed by positive market sentiment following earnings reports from Tesla and Broadcom.

21 jul 2026, 23:51 UTC

Recursion Pharmaceuticals Inc's shares are lower in after-market hours, settling down from Tuesday's close without any specific news to explain the movement.

21 jul 2026, 23:51 UTC

Zeta Global Holdings is higher in after-market trading, amid broader market strength following positive earnings from companies like Tesla and Broadcom.

21 jul 2026, 23:51 UTC

Intercontinental Exchange Inc shares are higher in after-market hours amid increased trading activity, remaining above their 20-day moving average and near a one-month high.

21 jul 2026, 23:51 UTC

Coca-Cola Europacific Partners PLC shares are lower in after-market hours amid notable volatility, with no specific company news identified to explain the movement.

21 jul 2026, 23:51 UTC

Starwood Property Trust shares rose in after-market trading amid positive market sentiment following earnings reports from companies like Tesla and Broadcom.

21 jul 2026, 23:51 UTC

NetEase Inc. shares are higher in after-market trading, reflecting positive sentiment from recent earnings reports of firms like Tesla and Broadcom.

21 jul 2026, 23:51 UTC

Correlated Moves

Nexgen Energy Ltd shares advanced in after-market trading, buoyed by positive sentiment following earnings reports from major companies like Tesla and Broadcom.

Comparación entre iguales

Cambio de precio

Novo Nordisk A-S (Class B) previsión

Precio Objetivo

By TipRanks

9.53% repunte

Estimación a 12 Meses

Media 1,162.73 DKK 9.53%

Máximo 1,550 DKK

Mínimo 720 DKK

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novo Nordisk A-S (Class B) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

Comprar

Mantener

Vender

De acuerdo con 11 analistas que ofrecen calificaciones bursátiles a para Novo Nordisk A-S (Class B) Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Novo Nordisk A-S (Class B)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.